Sagittarius Life Science Corp. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 114.440 million compared to TWD 95.418 million a year ago. Operating loss was TWD 28.996 million compared to TWD 26.250 million a year ago. Net loss was TWD 27.934 million compared to TWD 22.128 million a year ago. Basic loss per share was TWD 0.85 compared to TWD 0.67 a year ago. For the nine months, sales was TWD 331.049 million compared to TWD 313.547 million a year ago. Operating loss was TWD 79.909 million compared to TWD 77.999 million a year ago. Net loss was TWD 75.122 million compared to TWD 54.087 million a year ago. Basic loss per share was TWD 2.29 compared to TWD 1.65 a year ago.